Latest News

Health Discovery Corporation Partners with Major New York City Pancreatic Cancer Center to Develop a New Molecular Diagnostic Test for the Early Detection of Pancreatic Cancer

STRATIVA PHARMACEUTICALS PROVIDES AN UPDATE ON ZUPLENZ

Achillion Announces License Agreement for Elvucitabine Development in China

Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination with Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)

Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program

NEOPROBE COMPLETES RIGS ANTIBODY LICENSE AMENDMENTS

Anadys Pharmaceuticals Provides Progress Update on Phase II Study of ANA598 in Hepatitis C Patients

Pharmasset Initiates Phase 2a Trial with PSI-7977, a Chirally Pure Isomer of PSI-7851

Celsion Abstract Selected for Oral Presentation at 2010 IHPBA World Congress in Buenos Aires, Argentina

ONCOLOGY: PALONOSETRON APPROVED IN JAPAN, SECOND PHARMACEUTICAL MARKET WORLDWIDE

More news... | RSS Feed...

Most Viewed

NOVELOS THERAPEUTICS REACHES 725th EVENT IN PIVOTAL PHASE 3 LUNG CANCER TRIAL

OraSure Technologies Files Additional Data With FDA in Support of PMA Application for OraQuick Rapid HCV Test

ONCOLOGY: PALONOSETRON APPROVED IN JAPAN, SECOND PHARMACEUTICAL MARKET WORLDWIDE

Exclusive Distribution Agreement with Response Genetics, Inc.

Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium

McNeil Consumer Healthcare Announces Voluntary Recall of Certain Over-The-Counter (OTC) Products In The Americas, UAE, and Fiji

Boston Scientific Announces Enrollment of First Patient in Benign Stricture Study of WallFlex

Celsion Abstract Selected for Oral Presentation at 2010 IHPBA World Congress in Buenos Aires, Argentina

AspenBio Pharma Reports Progress on the Supplemental Clinical Trial, Work to Improve the Clinical Utility of AppyScore(TM) and Scheduled Meeting With FDA

NEOPROBE COMPLETES RIGS ANTIBODY LICENSE AMENDMENTS

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire